Growth Metrics

Oramed Pharmaceuticals (ORMP) Receivables - Net (2016 - 2018)

Oramed Pharmaceuticals filings provide 8 years of Receivables - Net readings, the most recent being $65000.0 for Q1 2018.

  • Quarterly Receivables - Net changed N/A to $65000.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $65000.0 through Feb 2018, changed N/A year-over-year, with the annual reading at $65000.0 for FY2017, 0.0% changed from the prior year.
  • Receivables - Net hit $65000.0 in Q1 2018 for Oramed Pharmaceuticals, roughly flat from $65000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $65053.0 in Q1 2014 and bottomed at $65000.0 in Q3 2014.
  • Average Receivables - Net over 5 years is $65007.1, with a median of $65000.0 recorded in 2014.
  • The largest annual shift saw Receivables - Net crashed 85.21% in 2014 before it changed 0.0% in 2015.
  • Oramed Pharmaceuticals' Receivables - Net stood at $65000.0 in 2014, then changed by 0.0% to $65000.0 in 2015, then changed by 0.0% to $65000.0 in 2016, then changed by 0.0% to $65000.0 in 2017, then changed by 0.0% to $65000.0 in 2018.
  • Per Business Quant, the three most recent readings for ORMP's Receivables - Net are $65000.0 (Q1 2018), $65000.0 (Q4 2017), and $65000.0 (Q3 2017).